Google
Apple
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
BAVARIAN NORDIC A/S |
Real-time Estimate
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 167.58 DKK | -2.74% | +0.69% | -21.23% | |
| 12-05 | Stigma, regulatory barriers delay mpox response in country that needs it most | RE |
| 11-20 | Nordic Shares Closed Up Monday; Better Collective Topped Leaders | DJ |
| Sales 2023 * | 6.89B 997M 79.2B | Sales 2024 * | 5.38B 778M 61.82B | Capitalization | 13.43B 1.94B 154B |
|---|---|---|---|---|---|
| Net income 2023 * | 1.15B 167M 13.24B | Net income 2024 * | 1.22B 177M 14.07B | EV / Sales 2023 * | 1,66x |
| Net cash position 2023 * | 1.99B 287M 22.82B | Net cash position 2024 * | 2.63B 380M 30.19B | EV / Sales 2024 * | 2,01x |
| P/E ratio 2023 * | 11,5x | P/E ratio 2024 * | 12,6x | Employees | 1,351 |
| Yield 2023 * | - | Yield 2024 * | - | Free-Float | 99.7% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -2.74% | ||
| 1 week | +0.69% | ||
| Current month | +0.69% | ||
| 1 month | +23.97% | ||
| 3 months | +19.56% | ||
| 6 months | -17.68% | ||
| Current year | -21.23% |
1 week
161.85
173.20
1 month
135.00173.20
Current year
125.55256.00
1 year
125.55256.00
3 years
115.20411.00
5 years
103.20411.00
10 years
81.50444.00
| Managers | Title | Age | Since |
|---|---|---|---|
Paul Chaplin
CEO | Chief Executive Officer | 56 | 1998 |
| Director of Finance/CFO | 58 | 2018 | |
Russell Thirsk
COO | Chief Operating Officer | 55 | 2022 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 2010 | |
Frank Verwiel
BRD | Director/Board Member | 60 | 2016 |
| Director/Board Member | 67 | 2012 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.81% | 23 M€ | +14.36% | ||
| 1.47% | 35 M€ | +12.16% | ||
| 0.96% | 117 M€ | 0.00% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/12/23 | 167.5 | -2.79% | 113 018 |
| 06/12/23 | 172.3 | -0.35% | 530,994 |
| 05/12/23 | 172.9 | +4.60% | 525,946 |
| 04/12/23 | 165.3 | +0.73% | 378,469 |
| 01/12/23 | 164.1 | -1.71% | 394,510 |
Delayed Quote Nasdaq Copenhagen, December 07, 2023 at 10:34 am
More quotes
Bavarian Nordic A/S specializes in the development, manufacturing and commercialization of cancer immunotherapies and vaccines for the prevention and treatment of infectious diseases.
Net sales by revenue source are divided between sales of products (95.8%) and services (4.2%).
Net sales are distributed geographically as follows: the United States (26.7%), Germany (20.6%), Belgium (10.6%), France (8.5%), Canada (6.3%), the United Kingdom (5.4%), Hong Kong (3.7%), Saudi Arabia (3.2%), Australia (3.1%), Switzerland (2.2%) and other (9.7%).
Sector
Pharmaceuticals
Calendar
25/02/2024
- Capital Market Day
Trading Rating :
Investor Rating :
ESG Refinitiv :
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
172.3DKK
Average target price
275.67DKK
Spread / Average Target
+59.99%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -21.23% | 1 943 M $ | |
| +61.07% | 530 B $ | |
| +43.33% | 438 B $ | |
| -11.34% | 377 B $ | |
| -4.79% | 268 B $ | |
| -9.42% | 258 B $ | |
| +0.81% | 200 B $ | |
| -9.84% | 198 B $ | |
| -43.81% | 163 B $ | |
| +2.55% | 144 B $ |
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition